Urinary 5-Hydroxyindolacetic Acid Measurements in Patients with Neuroendocrine Tumor-Related Carcinoid Syndrome: State of the Art

Urinary 5-Hydroxyindolacetic Acid Measurements in Patients with Neuroendocrine Tumor-Related Carcinoid Syndrome: State of the Art

Carcinoid syndrome (CS), mostly associated with small intestinal neuroendocrine tumors (SI-NETs) or lung-related NETs, is characterized by symptoms related to hormonal secretion and long-term complications, including carcinoid heart disease (CHD), which is potentially life-threatening. In the early...

Full description

Bibliographic Details
Main Authors: Roberta Elisa Rossi, Elisabetta Lavezzi, Simona Jaafar, Giacomo Cristofolini, Alice Laffi, Gennaro Nappo, Silvia Carrara, Alexia Francesca Bertuzzi, Silvia Uccella, Alessandro Repici, Alessandro Zerbi, Andrea Gerardo Antonio Lania
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Cancers
Subjects:
neuroendocrine tumors
small intestinal neuroendocrine tumors
carcinoid syndrome
5-hydroxyindolacetic acid
biomarkers
diagnosis
Online Access:https://www.mdpi.com/2072-6694/15/16/4065

Internet

https://www.mdpi.com/2072-6694/15/16/4065

Similar Items